Antiphospholipid antibody syndrome and pregnancy

S. Errarhay, N. Hmidani, S. Mahmoud, L. Labib, H. Saadi, M. Hrandou, C. Bouchikhi, A. Banani

Department of Gynecology and Obstetrics, University Hospital of Fez, Fez, Morocco.
Department of Reanimation, University Hospital of Fez, Fez, Morocco.

DOI: 10.4236/ojog.2013.34071                

Abstract

Recurrent foetal loss in early and late stages of pregnancy is a common problem of women affected by anti-phospholipid antibody syndrome. The therapeutic scheme consisting of associating aspirin and heparin has shown an improvement of the prognosis for the next pregnancies. We report 3 cases of anti-phospholipid antibody syndrome and pregnancy, and we underline the clinical, therapeutic and prognosis features of this syndrome.

Keywords

Anti-Phospholipid Antibody Syndrome; Pregnancy; Treatment; Prognosis

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Sibilia, J. (2003) Syndrome des antiphospholipides: Pourquoi faut-il y penser et comment faire le diagnostic. Revue du Rhumatisme, 70, 228-234. doi:10.1016/S1169-8330(03)00057-7
[2]	Carbonne, B. and Lejeune, V. (2003) Modalités thérapeutiques d’une maladie abortive d’origine dysimmunitaire. Gynécologie Obstétrique & Fertilité, 31, 789-793. doi:10.1016/S1297-9589(03)00210-8
[3]	Arvieux, J. and Hachulla, E. (2002) Le syndrome des antiphospholipides. Annales de Cardiologie et d Angéiologie, 51, 146-151. doi:10.1016/S0003-3928(02)00087-2
[4]	Firkin, B.G., Howard, M.A. and Radford, N. (1980) Possible relationship between lupus inhibitor and recurrent abortion in young women. Lancet, 2, 366. doi:10.1016/S0140-6736(80)90361-X
[5]	Lejeune, V. (2006) Fausses couches spontanées précoces répétées: Quelleprise encharge proposer en 2006? Gynécologie Obstétrique & Fertilité, 34, 927-993. doi:10.1016/j.gyobfe.2006.08.008
[6]	Nielsen, H.S. and Christiansen, O.B. (2005) Prognostic impact of anticardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant. Human Reproduction, 20, 1720-1728. doi:10.1093/humrep/deh790
[7]	Wilson, W.A., Gharavi, A.E. and Koike, T. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis & Rheumatism, 42, 1309-1311. doi:10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
[8]	De Maistre, E. (2003) Anticorps dits antiphospholipides et troubles de la reproduction: Les données biologiques. Gynécologie Obstétrique & Fertilité, 31, 794-796. doi:10.1016/S1297-9589(03)00207-8
[9]	Meyer, O. (2003) Lupus et autres connectivites et vie hormonale. Gynécologie Obstétrique & Fertilité, 31, 746-756. doi:10.1016/S1297-9589(03)00203-0
[10]	Branch, D.W., Peaceman, A.M., Druzin, M., et al. (2000) Multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. American Journal of Obstetrics & Gynecology, 122-182. doi:10.1016/S0 002-9378(00)70500-X
[11]	Xiong, J. and Zhu, F.F. (2013) Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome. Experimental and Therapeutic Medicine, 5, 287-291.
[12]	Shrimati, S. and Kanjaksha, G. (2009) Anti-phospholipid antibodies and other immunological causes of recurrent foetal loss: A review of literature of various therapeutic protocols. American Journal of Reproductive Immunology, 62, 9-24.